about
PD-L1 biomarker testing for non-small cell lung cancer: truth or fiction?Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic TargetingEffector, Memory, and Dysfunctional CD8(+) T Cell Fates in the Antitumor Immune ResponseTrends and advances in tumor immunology and lung cancer immunotherapyAdvances in Cancer Immunotherapy in Solid TumorsUsing Murine Models to Investigate Tumor-Lymphoid Interactions: Spotlight on Chronic Lymphocytic Leukemia and Angioimmunoblastic T-Cell Lymphoma.Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer.Type I and Type II Interferon Coordinately Regulate Suppressive Dendritic Cell Fate and Function during Viral PersistenceAnti-cancer effect of Annona Muricata Linn Leaves Crude Extract (AMCE) on breast cancer cell lineSuccesses and failures: what did we learn from recent first-line treatment immunotherapy trials in non-small cell lung cancer?New Strategies in Engineering T-cell Receptor Gene-Modified T cells to More Effectively Target MalignanciesThe prognostic value of peripheral CD4+CD25+ T lymphocytes among early stage and triple negative breast cancer patients receiving dendritic cells-cytokine induced killer cells infusion.Demethylation of the PD-1 Promoter Is Imprinted during the Effector Phase of CD8 T Cell Exhaustion.Depletion of FAP+ cells reduces immunosuppressive cells and improves metabolism and functions CD8+T cells within tumorsTumor-induced MDSC act via remote control to inhibit L-selectin-dependent adaptive immunity in lymph nodes.Tim-3 inhibits macrophage control of Listeria monocytogenes by inhibiting Nrf2.PD-L1 is a diverse molecule regulating both tumor-intrinsic signaling and adaptive immunosuppression.Predictive biomarkers for the efficacy of peptide vaccine treatment: based on the results of a phase II study on advanced pancreatic cancer.OMIP-036: Co-inhibitory receptor (immune checkpoint) expression analysis in human T cell subsets.Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy.The cryo-thermal therapy eradicated melanoma in mice by eliciting CD4+ T-cell-mediated antitumor memory immune response.A Century of Radiation Therapy and Adaptive ImmunityThe Era of Checkpoint Blockade in Lung Cancer: Taking the Brakes Off the Immune System.Immunotherapy in hepatocellular carcinoma: Primed to make a difference?Upregulation of Galectin-9 and PD-L1 Immune Checkpoints Molecules in Patients with Chronic Lymphocytic LeukemiaMiR-15a/16 deficiency enhances anti-tumor immunity of glioma-infiltrating CD8+ T cells through targeting mTOR.Extracellular Vesicles Transfer the Receptor Programmed Death-1 in Rheumatoid Arthritis.Transcriptional factor EB regulates macrophage polarization in the tumor microenvironment.Tumor immunotherapy: drug-induced neoantigens (xenogenization) and immune checkpoint inhibitors.Stimulation of Natural Killer Cell-Mediated Tumor Immunity by an IL15/TGFβ-Neutralizing Fusion Protein.Enhancement of PSMA-Directed CAR Adoptive Immunotherapy by PD-1/PD-L1 Blockade.Immunoregulatory functions of VISTA.Nutrients and the microenvironment to feed a T cell army.Systemic Immunity Is Required for Effective Cancer Immunotherapy.Clinical Implications of Cytotoxic T Lymphocyte Antigen-4 Expression on Tumor Cells and Tumor-Infiltrating Lymphocytes in Extrahepatic Bile Duct Cancer Patients Undergoing Surgery Plus Adjuvant Chemoradiotherapy.Metabolic reprogramming and apoptosis sensitivity: defining the contours of a T cell response.Hepatocellular carcinoma treatment: a comparative review of emerging growth factor receptor antagonists.Targeting the programmed cell death-1 pathway in rheumatoid arthritis.Metabolic reprogramming in the tumour microenvironment: a hallmark shared by cancer cells and T lymphocytes.The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction.
P2860
Q26741101-F14B05B0-2C47-4E26-BB9F-045202BC3FC4Q26742012-FCEE6EF6-7A2C-4838-A239-2C1324546112Q26744527-79BF8E4E-B30C-449B-975F-CD298BD56B17Q28067674-3FCBDDBC-2B1B-4928-B711-A8B2B1E56673Q28080113-372D20CB-9DB0-410A-924F-4266F28FAEF5Q33621881-E19A81D4-8884-4FDC-A3F9-1D775074F829Q33654352-AB5A6BAF-8F5D-4CD0-BBE1-143B1532EA44Q35903800-4A6BC743-4543-466C-BBD5-AAFCB5489AC8Q36112190-B45668DB-DA7C-4DED-96E5-10A82B4B9217Q36305457-D7F31BB4-3671-47D9-8F7C-D326E4905EB2Q36558375-8E717C5B-5598-4868-A22B-C5966F22DCFDQ36562375-C9861C54-80E6-4ACA-BFBA-BFF3607D9B61Q37252876-C3521102-7FBC-4C84-8761-1D294F2A262DQ37268993-A1434BF4-9227-43AC-83F7-634BBBD9E28EQ37544847-1C202D28-09CB-40B6-B75D-3BC7172A936AQ37644227-8A445C18-281A-4063-B4D8-9FF937F5CEEDQ37662425-DBB846E3-9055-4468-B550-63BC986FE550Q37671162-0AAC0A8B-EA88-4D38-9DDB-46D6C7CAEEBFQ37732151-F14BAC2A-6241-46AD-BFAF-FE74A5B683CAQ37736296-B34DC97F-5AB3-4125-9C65-92C7F26B0DC4Q37745399-5656E4EF-2618-4E07-A5AA-2EB9D287D4E9Q37747153-19810FFD-55CB-444A-AD57-419AF66BF244Q38401891-77241BAC-4107-4EF8-80CA-CC35A55A914BQ38625948-B1A1AF94-7D96-47AD-927D-F4ACA182D8B0Q38637044-7ED2C242-01A7-4A5C-A5B3-67C4521E4E2FQ38652482-75156260-3D29-435C-8C78-D3D0538895BEQ38695393-739506EC-C40E-4DA6-B5CD-24A09550F804Q38714697-5E9A1316-08FC-4FE5-A1A7-5525EEB15531Q38730989-DCFBCDE7-8C93-4483-AEDB-DAC0D3045F93Q38753973-E3569F41-8226-48F3-9891-4F524371E069Q38874911-2D3D7E19-9504-4E86-AE3B-06E14A3C50CFQ38930123-5841C262-17AD-4B77-9F48-8613FF65341DQ38974085-C44A1714-87DB-4D2C-A6BC-DAA631AE9EECQ39006805-16F59115-7700-42D4-874C-8EB6A5B61516Q39022564-939B2C07-C190-46E6-AF0B-6CC57A944629Q39143778-D6FBAC12-869B-4A72-9265-0A1161B4F281Q39307416-D871FEAE-E090-4D04-AFEB-EEFFCB43D1AFQ39344907-4FEE6E3A-1E6B-4940-B961-E49A9B7B290FQ39378337-AC96500B-C327-44AA-BF62-44A85F500159Q39518049-DD7D8380-5EFF-4144-9EA3-F92C6D20323E
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
T-cell exhaustion in the tumor microenvironment.
@ast
T-cell exhaustion in the tumor microenvironment.
@en
type
label
T-cell exhaustion in the tumor microenvironment.
@ast
T-cell exhaustion in the tumor microenvironment.
@en
prefLabel
T-cell exhaustion in the tumor microenvironment.
@ast
T-cell exhaustion in the tumor microenvironment.
@en
P2093
P2860
P921
P356
P1476
T-cell exhaustion in the tumor microenvironment.
@en
P2093
P2860
P356
10.1038/CDDIS.2015.162
P5008
P577
2015-06-18T00:00:00Z